Single-blind Multi-arm Experiment
Also known as: single-masked multi-arm trial, single-blind multi-group experiment, unidirectional blinding multi-arm design, SB-MAT
A single-blind multi-arm experiment is a controlled experimental design that simultaneously compares three or more treatment conditions while blinding participants — but not investigators — to their group assignment. This configuration reduces response bias driven by participants' expectations, preserves operational feasibility when full blinding is impractical, and allows direct pairwise and omnibus comparisons across multiple arms within a single study.
Key highlights
- Simultaneously evaluates multiple conditions in one study, reducing time and resources compared with a series of two-arm trials.
- Participant-side blinding substantially reduces response bias and demand characteristics relative to open-label multi-arm designs.
- Concurrent arms guarantee that all groups are exposed to identical contextual conditions, improving internal validity compared with sequential studies.
- Allows direct pairwise comparisons between all active arms and a shared control, increasing statistical efficiency.
- Flexible enough to accommodate dose-response exploration, active-control comparisons, and adaptive extensions within the same framework.
Intuition
This section is available to Pro members. Upgrade to Pro
How it works
This section is available to Pro members. Upgrade to Pro
When to use it
Use a single-blind multi-arm experiment when you need to compare three or more conditions in a single study and participant expectation effects are a meaningful threat to validity, but full double-blinding is operationally infeasible (e.g., because investigators must adjust dosing, monitor side effects, or administer treatments that differ visibly). It suits dose-finding studies, comparative effectiveness research, and behavioral or educational interventions where at least participant-side blinding can be achieved. Do NOT use this design when investigator knowledge of assignment could itself bias outcome assessment — in that case move to double-blind or employ blinded outcome assessors; when the number of arms inflates the sample requirement beyond recruitment capacity; or when the phenomenon is not amenable to controlled manipulation.
Strengths & limitations
- Simultaneously evaluates multiple conditions in one study, reducing time and resources compared with a series of two-arm trials.
- Participant-side blinding substantially reduces response bias and demand characteristics relative to open-label multi-arm designs.
- Concurrent arms guarantee that all groups are exposed to identical contextual conditions, improving internal validity compared with sequential studies.
- Allows direct pairwise comparisons between all active arms and a shared control, increasing statistical efficiency.
- Flexible enough to accommodate dose-response exploration, active-control comparisons, and adaptive extensions within the same framework.
- Sample size grows with the number of arms; power analysis must account for multiple comparisons, which can make recruitment challenging.
- Investigator knowledge of allocation may introduce assessment bias if outcome measurement involves subjective clinical judgment; blinded outcome assessment should be used where possible.
- Participant blinding is sometimes difficult to maintain — particularly when treatments differ in obvious sensory or experiential properties — and should be verified with a formal blinding integrity check.
- Managing multiple arms increases logistical complexity: supply chains, staff training, and protocol deviation monitoring all scale with arm count.
Common pitfalls
This section is available to Pro members. Upgrade to Pro
Applications
This section is available to Pro members. Upgrade to Pro
Frequently asked
What makes this design 'single-blind' rather than 'double-blind'?
In a single-blind design, only one party — typically participants — is unaware of treatment assignment. Investigators retain full knowledge of group allocation. In a double-blind design both participants and those directly measuring outcomes are masked. Single blinding is chosen when investigator knowledge is operationally necessary but participant awareness would distort self-reported or behavioral outcomes.
How many arms is too many?
There is no strict upper limit, but each additional arm increases total sample size requirements, logistical complexity, and the number of pairwise comparisons requiring correction. Three to six arms is the most common range in practice; beyond that, platform or adaptive trial designs with arm-dropping rules are often more efficient.
How should I handle multiple comparisons in a multi-arm study?
Decide a priori which comparisons are primary — typically each active arm versus a shared control — and which are secondary. Apply a correction appropriate to the structure: Dunnett's test is optimal for all-versus-control comparisons; Tukey's honest significant difference covers all pairwise contrasts; Bonferroni is conservative but universally applicable. Pre-registering the hierarchy protects against selective reporting.
Should I verify whether participant blinding actually worked?
Yes. A brief end-of-study questionnaire asking participants to guess their treatment assignment is best practice. If guesses substantially exceed chance accuracy, blinding was compromised and this must be reported as a limitation. The check does not fix broken blinding but enables readers to calibrate their confidence in the results.
Can this design be used outside clinical research?
Yes. The design is well suited to any field where multiple conditions are compared simultaneously and participant-side blinding is achievable — including educational research, UX testing, behavioral economics, and organizational psychology. The statistical framework (omnibus test followed by planned contrasts) applies regardless of discipline.
Sources
- 1.Friedman, L. M., Furberg, C. D., & DeMets, D. L. (2010). Fundamentals of Clinical Trials (4th ed.). Springer.ISBN 978-1441915849
- 2.Multi-arm clinical trial. Wikipedia.
You have read it. What now?
Cite this page
ScholarGate. (2026, June 3). Single-blind multi-arm experiment. ScholarGate. https://scholargate.app/experimental-design/single-blind-multi-arm-experiment